Abstract
Two triptycene-based ligands with pendant bromophenyl units have been prepared. These triptycene derivatives have been used as synthons for the synthesis of di and tri nuclear palladium complexes. The organic molecules and their corresponding organometallic complexes have been fully characterized using nuclear magnetic resonance (NMR), infrared (IR) spectroscopy and mass spectrometry. The mode of binding and effect of the complexes on pUC19 plasmid, calf thymus DNA and oligomer duplex DNA have been investigated by a host of analytical methods. The complexes brought about unwinding of supercoiled plasmid and the unwinding angle was found to be related to the binding affinity of the complexes with DNA, where both these parameters were guided by the structure of the complexes. Concentration-dependent inhibition of endonuclease activity of SspI and BamHI by the complexes indicates preference for G/C sequence for binding to DNA. However, neither the complexes did not introduce any cleavage at abasic site in oligomer duplex DNA, nor they created linear form of the plasmid upon co-incubation with the DNA samples. The interactions of the complexes with DNA were found to be strongly guided by the structure of the complexes, where intercalation as well as groove binding was observed, without inflicting any damage to the DNA. The mode of interaction of the complexes with DNA was further confirmed by isothermal calorimetry.
Graphical abstract
Similar content being viewed by others
References
Bartlett PD, Ryan MJ, Cohen SG (1942) J Am Chem Soc 64:2649–2653
Jiang Y, Chen CF (2011) Eur J Org Chem 32:6377–6403
Chen CF (2011) Chem Commun 47:1674–1688
Zhao LW, Li Z, Wirth T (2010) Chem Lett 39:658–667
Chong JH, MacLachlan MJ (2009) Chem Soc Rev 38:3301–3315
Swager TM (2008) Acc Chem Res 41:1181–1189
Hoogboom J, Swager TM (2006) J Am Chem Soc 128:15058–15059
Perchellet EM, Magill MJ, Huang X, Brantis CE, Hua DH, Perchellet JP (1999) Anti Cancer Drugs 10:749–766
Wang B, Perchellet EM, Wang Y, Tamura M, Hua DH, Perchellet JP (2003) Anticancer Drugs 14:503–514
Perchellet EM, Wang Y, Lou K, Zhao H, Battina SK, Hua DUYH et al (2007) Anticancer Res 27:3259–3272
Perchellet EM, Sperfslage BJ, Wang Y, Huang X, Tamura M, Hua DH, Perchellet JP (2002) Anticancer Drugs 13:567–582
Perchellet EM, Wang Y, Webe RL, Lou K, Hua DH, Perchellet JP (2004) Anticancer Drugs 15:929–946
Wang Y, Perchellet EM, Tamura M et al (2002) Cancer Lett 188:73–83
Chaires JB (1998) Curr Opin Struct Biol 8:314–320
Tse WC, Boger DL (2004) Chem Biol 11:1607–1617
Lipscomb LA, Zhou FX, Presnell SR, Woo RJ, Pee ME, Plaskon RR, Williams LD (1996) Biochemistry 35:2818–2823
Krishnan P, Bastow KF (2000) Anti cancer Drug Des 15:255–264
Weder E, Hambley TW, Kennedy BJ, Lay PA, Foran GJ, Rich AM (2001) Inorg Chem 40:1295–1302
Zhou Q, Hambley TW, Kennedy BJ, Lay PA, Turner P, Warwick B, Biffin JR, Regtop HL (2000) Inorg Chem 39:3742–3748
Gonzalez-Pantoja JF, Stern M, Jarzecki AA, Royo E et al (2011) Inorg Chem 50:11099–11110
Carreira M, Sanjuán RC, Sanaú M, Zhao X, Magliozzo RS, Marzo I, Contel M (2012) J Inorg Biochem 116:204–214
Gao E, Zhu MC, Yin H, Liu L, Wu Q, Sun Y (2008) J Inorg Biochem 102:1958–1964
Mishra A, Kumar SR, Hong SH, Kim H, Vajpayee V, Lee HW, Ahn BC, Wang M, Stang PJ, Chi KW (2011) Organometallics 30:6343–6346
Peruzzini M, Gonsalvi L, Romerosa A (2005) Chem Soc Rev 34:1038–1047
Cook TR, Vajpayee V, Lee MH, Stang PJ, Chi K (2013) Acc Chem Res 46:2464–2474
Gao E, Zhu M, Liu L, Huang Y, Wang L, Shi S, Chuyue Z, Sun WY (2010) Inorg Chem 49:3261–3270
Gao E, Liu C, Zhu M, Lin H, Wu Q, Liu L (2009) Anticancer Agents Med Chem 9:356–368
Messere A, Fabbri E, Borgatti M, Gambari R, Blasio BD, Pedone C, Romanelli A (2007) J Inorg Biochem 101:254–260
García-Friaza G, Fernández-Botello A, Pérez JM, Prieto MJ, Moreno V (2006) J Inorg Biochem 100:1368–1377
Paul AK, Torshizi HM, Srivastava TS, Chavan SJ, Chitnis MP (1993) J Inorg Biochem 50:9–20
Soledad Betanzos-Lara S, Novakova O, Deeth RJ, Pizarro AM, Clarkson GJ, Liskova B, Brabec V, Sadler PJ, Habtemariam A (2012) J Biol Inorg Chem 17:1033–1051
Malina J, Hannon MJ, Brabec V (2008) Nucleic Acids Res 36:3630–3638
Lee M, Rhodes AL, Wyatt MD, Forrow S, Hartley JA (1993) Biochemistry 15:4339–4345
Wyatt MD, Garbiras BJ, Haskel MK, Lee M, Souhami RL, Hartley JA (1994) Anti-Cancer Drug Des 1:511–529
McKnight RE, Reisenauer E, Pintado MV, Shivani R, Dixon DW (2011) Bioorg. Med. Chem. Lett. 21:4288–4291
Manna J, Kuehl CJ, Whiteford JA, Stang PJ (1997) Organometallics 16:1897–1905
Jaramillo D, Wheate NJ, Ralph SF, Howard WA, Tor Y, Wright JRA (2006) Inorg Chem 45:6004–6012
Zhang AG, Zhang YZ, Duan ZM, Wang KZ, Wei HB, Bian ZQ, Huang CH (2011) Inorg Chem 50:6425–6461
Byrne CD, deMello AJ (1998) Biophys Chem 70:173–184
Liu ZC, Wang BD, Yang ZY, Li Y, Qin DD, Li TR (2009) Eur J Med Chem 44:4477–4484
Coban B, Yildiz U, Sengul A (2013) J Biol Inorg Chem 18:461–471
Nastasi M, Morris JM, Rayner DM, Seligy VI, Szabo AG, Williams DF, Williams RE, Yip RW (1976) J Am Chem Soc 98:3979–3986
Kyros L, Banti CN, Kourkoumelis N, Kubicki M, Sainis I, Hadjikakou SK (2014) J Biol Inorg Chem. doi:10.1007/s00775-014-1089-6
Nair RB, Teng ES, Kirkland SL, Murphy C (1998) Inorg Chem 37:139–141
Thomas M, Varshney U, Bhattacharya S (2002) Eur J Org Chem 2002:3604–3615
Rajendran A, Nair BU (2006) Biochim Biophys Acta 1760:1794–1801
Clarke MJ, Jansen B, Marx KA, Kruger R (1986) Inorg Chim Acta 124:13–28
Maheswari PU, Palaniandavar M (2004) J Inorg Biochem 98:219–230
Wilson WD, Tanious FA, Barton HJ, Jones RL, Fox K, Wydra RL, Strekowski L (1990) Biochemistry 29:8452
Bailly C, Colson P, Henichart JP, Houssier C (1993) Nucleic Acids Res 21:3705
Chaires JB (1997) Biopolymers 44:201
Wilson WD (1999) DNA intercalators. In: Kool ET (ed) DNA and aspects of molecular biology. Elsevier, New York, pp 427–476
Utsuno K, Maeda Y, Tsubo M (1999) Chem Pharm Bull 47:1363–1368
Puvvada MS, Hartley JA, Jenkins TC, Thurston DE (1993) Nucleic Acids Res 21:3671–3675
Gonzalez VM, Aknso PC (1997) J Inorg Biochem 68:283–287
Acknowledgments
This work was supported by a Grant to P. D. and N. D from Department of Biotechnology (DBT), Govt. of India, Project No. BT/PR3444/NNT/28/560/2011. R. K. and S. B. are thankful to IIT Patna for fellowship. Authors are thankful to Prof. P. K. Das of IACS, Kolkata for help with CD facility. All the authors gratefully acknowledge the availability of Infrastructural and experimental facilities provided by IIT Patna. The authors also acknowledge SID, IISc Bangalore and SAIF, Punjab University for analytical facilities.
Author contribution statement
All authors have contributed to the idea, the designing and planning of the studies as well as interpretation and discussion of the results. S.B. synthesized the triptycene based organic ligands and their corresponding organometallic complexes. R.K. carried out the experiments related to evaluation of biological activity of triptycene based molecules reported herein. All authors have contributed to compiling the manuscript and have approved the final manuscript.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kumari, R., Bhowmick, S., Das, N. et al. Binding and interaction of di- and tri-substituted organometallic triptycene palladium complexes with DNA. J Biol Inorg Chem 19, 1221–1232 (2014). https://doi.org/10.1007/s00775-014-1180-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-014-1180-z